| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/19/2011 | US7928204 monoclonal antibodies specific for Bacillus anthracis relative to the vegetative form of the cells; detecting the presence/absence of these spores |
| 04/19/2011 | US7928203 Chimeric, humanized, or human antibody 2A4 |
| 04/19/2011 | US7928202 Targeting ABCB5 for cancer therapy |
| 04/19/2011 | US7928201 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/19/2011 | US7928200 Human genes relating to respiratory diseases and obesity |
| 04/19/2011 | US7928193 Antigen binding proteins directed against scavenger receptor B1 that inhibit HCV replication |
| 04/19/2011 | US7928187 Neuropeptide alarin |
| 04/19/2011 | US7928186 Cell permeable bioactive peptide conjugates |
| 04/19/2011 | US7928074 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders |
| 04/19/2011 | US7928073 Purified polypeptides having IL-13 receptor activity |
| 04/19/2011 | US7928071 Nucleotide and protein sequences of vertebrate delta genes and methods based thereon |
| 04/19/2011 | US7928061 Endothelial growth factor; isolated polypeptide; stimulates cell proliferation, neovascularization, vascular system permeability; uses thereof in medical and diagnostic applications |
| 04/19/2011 | US7928057 Peptide for inhibition of calcineurin, nucleic acid, antibody, and diagnostic and therapeutic methods of use |
| 04/19/2011 | US7927863 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
| 04/19/2011 | US7927835 Expression vector comprising nucleotide sequences coding bone morphogenic protein/selectin fusion for use in treatment and prvention of inflammatory diseases |
| 04/19/2011 | US7927834 Recombinant production of mixtures of antibodies |
| 04/19/2011 | US7927824 Complex of a chaperone with β-amyloid and methods employing this complex |
| 04/19/2011 | US7927823 Assays using chimeric T1R3 taste receptor polypeptides |
| 04/19/2011 | US7927817 Hybrid antibodies |
| 04/19/2011 | US7927811 Binds to cerebrovascular endothelial cell; expression vectors; micelle, liposome or microcapsule used as carriers |
| 04/19/2011 | US7927806 Distinguishing PCA3 messenger RNA species in benign and malignant prostate tissues |
| 04/19/2011 | US7927803 Human MutY |
| 04/19/2011 | US7927605 Diagnosing and preventing microorganismal infections using iron-restricted conditions; genetic vaccines |
| 04/19/2011 | US7927596 Methods of antagonizing binding of CD40 to CD40L with CD40L-specific monovalent polypeptides |
| 04/19/2011 | US7927595 Methods for downregulating CCR5 in T cells with anti-CD3 antibodies and anti-CD28 antibodies |
| 04/19/2011 | US7927593 TGF-beta binding antibodies |
| 04/19/2011 | US7927592 Method of inhibiting complement activation |
| 04/19/2011 | US7927591 Protein; an immunoglobulin heavy chain variable domain sequence and an immunoglobulin light chain variable domain sequence forming an antigen binding site; inhibiting a binding interaction between aLFA-1 and a cognate ligand of aLFA-; inflammatory disorders |
| 04/19/2011 | US7927583 Receptor based antagonists and methods of making and using |
| 04/19/2011 | US7927579 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 04/19/2011 | CA2515322C Leukocyte stimulating peptides |
| 04/19/2011 | CA2451680C Human dr4 antibodies and uses thereof |
| 04/19/2011 | CA2421258C Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 04/19/2011 | CA2399047C Reagents and methods useful for detecting diseases of the breast |
| 04/19/2011 | CA2392158C Detergent compositions comprising benefit agents |
| 04/19/2011 | CA2378778C Il-16 antagonists |
| 04/19/2011 | CA2220116C Dna encoding glutamate gated chloride channels |
| 04/19/2011 | CA2185859C Preparation of virally inactivated intravenously injectable immune serum globulin |
| 04/19/2011 | CA2166117C Gene sequence for spinocerebellar ataxia type 1 and method for diagnosis |
| 04/14/2011 | WO2011044570A2 Recombinant antibodies against h1n1 influenza |
| 04/14/2011 | WO2011044336A2 Human domain antibodies against components of the human insulin-like growth factor (igf) system |
| 04/14/2011 | WO2011043643A1 Rsv-specific binding molecule |
| 04/14/2011 | WO2011043530A1 Glp-1 analog fusions, and composition for preventing or treating diabetes containing the fusions as an active ingredient |
| 04/14/2011 | WO2011043332A1 Susceptibility gene for hair shapes |
| 04/14/2011 | WO2011042891A1 Monovalent ligands of the human cd28 receptor |
| 04/14/2011 | WO2011042548A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| 04/14/2011 | WO2011042534A1 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer |
| 04/14/2011 | WO2011042398A1 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them |
| 04/14/2011 | WO2011042026A1 A cytolytic rtx-toxin from gallibacterium anatis |
| 04/14/2011 | WO2011041894A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | WO2011041839A1 Udp-galactopyranose mutase from haemonchus contortus, and rnai agents that inhibit it |
| 04/14/2011 | WO2011022103A3 Ganglioside epitopes for treating guillain-barre syndrome |
| 04/14/2011 | WO2011022077A3 A nucleic acid cassette for producing recombinant antibodies |
| 04/14/2011 | WO2011017791A9 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum |
| 04/14/2011 | WO2011012254A8 Pichia pastoris as a host for the production of the ribosome-inactivating protein (rip) saporin and saporin fusion chimaeras |
| 04/14/2011 | WO2010121208A3 New methods of making an antibody and compositions thereof |
| 04/14/2011 | WO2010117455A3 Human monoclonal antibodies protective against bubonic plaque |
| 04/14/2011 | WO2010096470A4 Method for inhibiting neurodegeneration |
| 04/14/2011 | WO2001085798A9 Human monoclonal antibodies to dendritic cells |
| 04/14/2011 | US20110088104 Novel antibodies for the treatment of hiv |
| 04/14/2011 | US20110087010 Anti-angiogenic compounds |
| 04/14/2011 | US20110087007 Cytokine-Like Proteins |
| 04/14/2011 | US20110086800 Screening method for predicting susceptibility to breast cancer |
| 04/14/2011 | US20110086422 Humanized antibodies to interferon alpha receptor-1 (ifnar-1) |
| 04/14/2011 | US20110086416 Immunotoxin fusion proteins and means for expression thereof |
| 04/14/2011 | US20110086404 Method for monitoring, diagnosing, and screening cancer through measuring the concentration of des-r prothrombin activation peptide fragment f2 (des-r f2) in a serum |
| 04/14/2011 | US20110086372 Biomarkers associated with nephropathy |
| 04/14/2011 | US20110086371 Urine and serum biomarkers associated with diabetic nephropathy |
| 04/14/2011 | US20110086364 Detection of cannabis use |
| 04/14/2011 | US20110086360 Method for detection of idiopathic interstitial pneumonia |
| 04/14/2011 | US20110086340 Methods, devices, kits and compositions for detecting roundworm |
| 04/14/2011 | US20110086050 Glycoprotein compositions |
| 04/14/2011 | US20110086049 Receptor Modulators |
| 04/14/2011 | US20110086047 Fc receptor homolog antibodies and uses thereof |
| 04/14/2011 | US20110086046 Treatment of MS with goat serum |
| 04/14/2011 | US20110086045 Method for enhancing growth or increasing feed efficiency through reducing binding between endotoxin and its receptor in the gastrointestinal tract |
| 04/14/2011 | US20110086042 Centrosomal Proteins, Nucleic Acids and Method of Use Thereof |
| 04/14/2011 | US20110086041 Fusion-Intermediate State of HIV-1 gP41 Targeted by Broadly Neutralizing Antibodies |
| 04/14/2011 | US20110086037 Method of treating inflammatory disorders |
| 04/14/2011 | US20110086036 Composition comprising vlp and amyloid beta peptide |
| 04/14/2011 | US20110086035 Immunotherapeutic methods and molecules |
| 04/14/2011 | US20110086034 Nucleotide and protein sequences of nogo genes and methods based thereon |
| 04/14/2011 | US20110086033 Method of inhibiting osteoclast activity |
| 04/14/2011 | US20110086029 Novel antibodies against cancer target block tumor growth, angiogenesis and metastasis |
| 04/14/2011 | US20110086028 Prevention of hiv infection |
| 04/14/2011 | US20110086027 Anti-cxcr4 antibodies |
| 04/14/2011 | US20110086026 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 04/14/2011 | US20110086019 Polypeptides, antibody variable domains and antagonistsmethods for |
| 04/14/2011 | US20110086004 Methods of treating cancer using il-21 and monoclonal antibody therapy |
| 04/14/2011 | US20110085981 Glycan-based drugs, therapies and biomarkers |
| 04/14/2011 | US20110085973 Methods and Agents for the Diagnosis and Treatment of Hepatocellular Carcinoma |
| 04/14/2011 | US20110085970 Anti-b7h4 monoclonal antibody-drug conjugate and methods of use |
| 04/14/2011 | DE102009045006A1 Anti-CD33 Antikörper und ihre Anwendung zum Immunotargeting bei der Behandlung von CD33-assoziierten Erkrankungen Anti-CD33 antibodies and their use for Immunotargeting in the treatment of CD33-associated diseases |
| 04/14/2011 | CA2777237A1 Polypeptides for binding to the "receptor for advanced glycation endproducts" as well as compositions and methods involving the same |
| 04/14/2011 | CA2777222A1 Il-17 family cytokine compositions and uses |
| 04/14/2011 | CA2776385A1 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use |
| 04/14/2011 | CA2775793A1 Siglec 15 antibodies in treating bone loss-related disease |
| 04/14/2011 | CA2775634A1 Chimeric antibodies specific for cd151 and use thereof in the treatment of cancer |
| 04/14/2011 | CA2775573A1 Generation, characterization and uses thereof of anti-her 3 antibodies |
| 04/14/2011 | CA2774953A1 Human domain antibodies against components of the human insulin-like growth factor (igf) system |